Sangeeta N. Bhatia - 01 May 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
01 May 2022
Net transactions value
$0
Form type
4
Filing time
03 May 2022, 16:47:39 UTC
Previous filing
12 Apr 2022
Next filing
04 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Award $0 +1,449 +28% $0.000000 6,640 01 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.